STABILITY TESTING SHOULD COME BEFORE BIOEQUIVALENCE STUDIES, FDA's ISE RECOMMENDS; FDAer ALSO CAUTIONS ABOUT EARLY DISSOLUTION TEST SUBMISSIONS